Array Biopharma (ARRY) Gives Up Earlier Gains; Falls 2%
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Yesterday's momentum stock du jour Array Biopharma (NASDAQ: ARRY) has broken lower after opening sharply higher. Shares are down 2% after gaining 81% on Monday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Weight Watchers (WTW) Climbs to Session High, Gaining 9%
- Options expected to have Increasing volume
- Target (TGT) volatility flat into announcing comparable sales during the combined November/December period decreased 1.3%
Create E-mail Alert Related CategoriesMomentum Movers, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!